D.E. Shaw & Co’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-737,069
Closed -$7.64M 5779
2022
Q2
$7.64M Buy
737,069
+453,391
+160% +$3.37M 0.01% 1661
2022
Q1
$2.5M Sell
283,678
-48,183
-15% -$365K ﹤0.01% 3091
2021
Q4
$2.3M Buy
331,861
+90,217
+37% +$1.32M ﹤0.01% 3227
2021
Q3
$3M Sell
241,644
-98,022
-29% -$1.41M ﹤0.01% 2630
2021
Q2
$6.2M Sell
339,666
-72,963
-18% -$1.45M 0.01% 1869
2021
Q1
$8.61M Buy
412,629
+97,606
+31% +$2.06M 0.01% 1462
2020
Q4
$5.63M Buy
315,023
+138,303
+78% +$2.08M 0.01% 1781
2020
Q3
$2M Sell
176,720
-300,904
-63% -$3.72M ﹤0.01% 2406
2020
Q2
$6.51M Sell
477,624
-210,144
-31% -$2.89M 0.01% 1467
2020
Q1
$8.94M Sell
687,768
-292,309
-30% -$5.21M 0.01% 1057
2019
Q4
$19.8M Sell
980,077
-257,103
-21% -$6.24M 0.02% 825
2019
Q3
$31.9M Sell
1,237,180
-247,140
-17% -$6.06M 0.04% 569
2019
Q2
$36.2M Buy
1,484,320
+542,670
+58% +$11.9M 0.05% 490
2019
Q1
$18.8M Buy
941,650
+286,310
+44% +$5.22M 0.02% 761
2018
Q4
$10.8M Buy
655,340
+266,361
+68% +$4.48M 0.01% 1041
2018
Q3
$6.92M Buy
388,979
+31,568
+9% +$714K 0.01% 1347
2018
Q2
$10.5M Buy
357,411
+312,472
+695% +$9.87M 0.01% 1056
2018
Q1
$1.61M Sell
44,939
-195,970
-81% -$7.08M ﹤0.01% 2184
2017
Q4
$7.65M Buy
+240,909
New +$7.56M 0.01% 1202
2017
Q2
Sell
-30,674
Closed -$1.19M 3599
2017
Q1
$1.19M Buy
30,674
+7,201
+31% +$302K ﹤0.01% 2196
2016
Q4
$893K Sell
23,473
-502
-2% -$23.9K ﹤0.01% 2529
2016
Q3
$1.3M Buy
+23,975
New +$1.22M ﹤0.01% 2223
2016
Q1
Sell
-7,980
Closed -$491K 3878
2015
Q4
$491K Sell
7,980
-127
-2% -$8.02K ﹤0.01% 3106
2015
Q3
$562K Sell
8,107
-2,638
-25% -$183K ﹤0.01% 2981
2015
Q2
$727K Sell
10,745
-33,421
-76% -$1.56M ﹤0.01% 2920
2015
Q1
$1.82M Buy
+44,166
New +$1.98M ﹤0.01% 2089

Other funds holding RDUS

D.E. Shaw & Co's RDUS Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 737,069 shares — an estimated $7.64M sold.

D.E. Shaw & Co first reported a position in RDUS in Q1 2015 and held it in 26 quarters. The position peaked at $36.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 737,069 Radius Health, Inc. shares in Q3 2022, an estimated $7.64M.
  • D.E. Shaw & Co first reported a position in Radius Health, Inc. in Q1 2015 and held it in 26 quarters.
  • D.E. Shaw & Co's Radius Health, Inc. position peaked at $36.2M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.